Materiality
85.25
Source
External coverage
Decided
2026-08-04
Mixed Pfizer signal: quarterly results beat estimates and non-Covid products supported guidance, but full-year Covid-product revenue expectations fell to $4 billion from about $5 billion.
View event details1 more curated

